|
- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis8 _0 R. q3 d: A
was to close its brain research facility in Basel, Switzerland,
( C6 ~8 ? \/ H: x1 V) sthe story noted that this move closely followed similar cuts
/ O5 u" v5 P3 j) W5 kby rival pharmaceutical firms. As a report from the European College. a) {( A ^% W, y# S
of Neuropsychopharmacology. C4 Y1 G; i7 n+ f& I# @, r# f7 G
had warned a few months earlier, the
6 @% u! ^' T# Kabandonment of research into new psychiatric drugs by AstraZeneca,, u& z0 b8 c7 S% H9 ~- a, D
GlaxoSmithKline( C5 j5 g v6 g6 a
and others meant that “withdrawal of research
3 P$ R5 F0 _- r0 _resources is a withdrawal of hope for patients and their families”.( P& @6 J% b7 {5 F; c
, l" g5 y; u: X) z
) X5 N* \% v6 Z8 d" t
回复有免费下载链接# ^* o' `7 U6 F* h2 V5 e! C
& @: j' k% _/ p, ~1 {) [7 |* h |
-
总评分: 包包 + 20
查看全部评分
|
发表于 2013-10-12 08:22
发表于 2013-10-12 08:44
